welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
- Hereditary Colorectal Cancer Syndromes and Genetic TestingColorectal cancer (CRC) is a leading cau...
- Dealing with Ostomy LeaksNothing can be more upsetting to an osto...
- Ureteric Obstruction in Familial Adenomatous Polyposis-Associated Desmoid DiseasePURPOSE : Intra-abdominal desmoid diseas...
- Huntsman Cancer Institute study delves into reasons why preventive drug is effectiveA potent preventive treatment for people...
- familial adenomatous polyposis and papillary thyroid cancerI recently saw a 35-year-old man with a ...
- Desmoid Tumors — Dangerous when not Treated as Cancerhttps://www.youtube.com/watch?v=gPcEJ8kA...
- Adrenocortical Secreting Mass in a Patient with Gardner’s Syndrome: A Case ReportGardner's syndrome (GS) is a dysplasia c...